| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Royalty Pharma plc | $57.80 | 1.5% | $24.76B | 32.1 | -23.7% | 1.2% | Healthcare | 62.4% | 7.8% | ||
| 2 | Ligand Pharmaceuticals Incorporated | $319.43 | -0.3% | $6.4B | 52.1 | 203.5% | — | Healthcare | 180.8% | 51.2% | ||
| 3 | Innoviva, Inc. | $22.25 | 2% | $1.64B | 6.7 | 683.1% | — | Healthcare | 17.7% | 13.6% | ||
| 4 | BlackRock Technology and Private Equity Term Trust | $8.44 | -2.9% | $985M | 49.6 | — | 10.1% | Healthcare | 15% | — | ||
| 5 | Cibus, Inc. | $1.50 | 6.4% | $978M | -0.5 | 84.8% | — | Healthcare | 2% | -9.8% | ||
| 6 | XOMA Royalty Corp. | $43.89 | 0.1% | $550M | 30.1 | 317.4% | 0.7% | Healthcare | 67.7% | -3.3% | ||
| 7 | XOMA Corporation | $24.97 | 0% | $301M | 17.1 | 469% | 1.2% | Healthcare | -2.8% | -36.1% | ||
| 8 | CDT Equity Inc. | $0.44 | -3.1% | $17334 | -0.0 | 99.3% | — | Healthcare | -99.9% | — |